Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,981.66 +1,765.03 (+2.71%) CMC Crypto 200
1,367.70 -6.15 (-0.45%)
Marker Therapeutics, Inc. (MRKR)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 36.55M |
| Enterprise value | 18.42M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.06 |
| Price/book (mrq) | 2.60 |
| Enterprise value/revenue | 3.41 |
| Enterprise value/EBITDA | -0.22 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 219.23% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 9.6800 |
| 52-week low 3 | 1.1600 |
| 50-day moving average 3 | 4.3502 |
| 200-day moving average 3 | 4.2747 |
Share statistics
| Avg vol (3-month) 3 | 17.45k |
| Avg vol (10-day) 3 | 9.65k |
| Shares outstanding 5 | 8.91M |
| Implied shares outstanding 6 | 9.07M |
| Float 8 | 6.76M |
| % held by insiders 1 | 12.20% |
| % held by institutions 1 | 22.78% |
| Shares short (30 Apr 2024) 4 | 53.87k |
| Short ratio (30 Apr 2024) 4 | 2.84 |
| Short % of float (30 Apr 2024) 4 | 0.84% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.60% |
| Shares short (prior month 28 Mar 2024) 4 | 107.89k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 16 Sept 2016 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 27 Jan 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -170.50% |
| Operating margin (ttm) | -204.89% |
Management effectiveness
| Return on assets (ttm) | -38.13% |
| Return on equity (ttm) | -88.18% |
Income statement
| Revenue (ttm) | 3.32M |
| Revenue per share (ttm) | 0.38 |
| Quarterly revenue growth (yoy) | 0.80% |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -12.21M |
| Diluted EPS (ttm) | -1.5900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 11.32M |
| Total cash per share (mrq) | 1.27 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 6.12 |
| Book value per share (mrq) | 1.33 |
Cash flow statement
| Operating cash flow (ttm) | -14.39M |
| Levered free cash flow (ttm) | -7.65M |
© 2024 Yahoo. All rights reserved.